US Stock MarketDetailed Quotes

CNS Pharmaceuticals (CNSP)

Watchlist
  • 7.370
  • +1.170+18.87%
Close Jan 15 16:00 ET
  • 6.840
  • -0.530-7.19%
Post 20:01 ET
4.57MMarket Cap-0.32P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

CNS Pharmaceuticals (CNSP) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
68.03%-2.17M
-223.76%-5.34M
-1.56%-3.24M
-21.03%-17.11M
-115.70%-5.47M
-101.40%-6.8M
51.50%-1.65M
33.84%-3.19M
-33.93%-14.14M
-10.02%-2.54M
Net income from continuing operations
42.59%-3.22M
6.16%-2.37M
-21.34%-4.3M
21.18%-14.86M
40.91%-3.18M
-23.95%-5.61M
37.07%-2.53M
28.13%-3.54M
-23.42%-18.85M
-4.64%-5.38M
Operating gains losses
----
----
----
-138.15%-190
--0
--0
--0
---190
-83.99%498
-154.41%-259
Depreciation and amortization
-7.19%697
46.41%1.1K
34.47%1.1K
-20.03%3.31K
3.36%985
-16.46%751
-25.02%752
-36.04%818
-64.83%4.13K
-59.97%953
Other non cash items
----
----
----
--596.3K
--1
----
----
----
----
----
Change In working capital
149.70%1.03M
-563.57%-2.99M
567.84%995.95K
-199.86%-3.69M
-193.09%-2.43M
-317.13%-2.06M
96.85%645.26K
180.94%149.13K
16.90%3.7M
18.17%2.61M
-Change in prepaid assets
-27.10%401.66K
-1,350.83%-1.68M
505.05%623.16K
-102.52%-59.97K
-174.71%-597.9K
-26.92%550.99K
-188.70%-116.06K
-85.12%102.99K
176.28%2.38M
391.67%800.26K
-Change in payables and accrued expense
125.53%667.2K
-271.73%-1.31M
708.01%372.78K
-374.91%-3.63M
-201.23%-1.83M
-1,432.80%-2.61M
286.57%761.32K
105.26%46.14K
-42.62%1.32M
-27.18%1.81M
Cash from discontinued investing activities
Operating cash flow
68.03%-2.17M
-223.76%-5.34M
-1.56%-3.24M
-21.03%-17.11M
-115.70%-5.47M
-101.40%-6.8M
51.50%-1.65M
33.84%-3.19M
-33.93%-14.14M
-10.02%-2.54M
Investing cash flow
Cash flow from continuing investing activities
-7.36%-4.19K
-94.16%-4.19K
11.78%-3.9K
-215,800.00%-2.16K
Net PPE purchase and sale
----
----
----
-7.36%-4.19K
-94.16%-4.19K
----
----
----
11.78%-3.9K
-215,800.00%-2.16K
Cash from discontinued investing activities
Investing cash flow
----
----
----
-7.36%-4.19K
-94.16%-4.19K
----
----
----
11.78%-3.9K
-215,800.00%-2.16K
Financing cash flow
Cash flow from continuing financing activities
-100.75%-91.62K
90.20%4.43M
184.17%9.83M
396.63%23.03M
127.92%4.96M
146,826.13%12.28M
-9.52%2.33M
2,975.33%3.46M
-70.30%4.64M
-59.17%2.18M
Net issuance payments of debt
1.18%-90.97K
1.06%-88.91K
0.93%-86.88K
31.44%-300.81K
55.87%-31.19K
26.05%-92.06K
26.76%-89.86K
27.45%-87.7K
-2.58%-438.73K
10.73%-70.67K
Net common stock issuance
-100.01%-1.49K
86.09%4.51M
155.60%9.03M
908.65%23.38M
2,220.75%5M
9,244.01%12.41M
23.12%2.42M
--3.53M
-85.55%2.32M
-96.02%215.64K
Proceeds from stock option exercised by employees
--844
-68.80%2.78K
--0
-99.28%21.33K
-100.00%-1
--0
-98.77%8.92K
1,936.95%12.41K
108,211.59%2.96M
1,894,451.69%2.24M
Net other financing activities
--0
--0
--882.54K
67.10%-66.75K
---10K
---40K
----
----
---202.86K
----
Cash from discontinued financing activities
Financing cash flow
-100.75%-91.62K
90.20%4.43M
184.17%9.83M
396.63%23.03M
127.92%4.96M
146,826.13%12.28M
-9.52%2.33M
2,975.33%3.46M
-70.30%4.64M
-59.17%2.18M
Net cash flow
Beginning cash position
713.23%12.13M
1,500.49%13.05M
1,077.53%6.46M
-94.54%548.72K
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
100.93%10.06M
-87.06%909.55K
Current changes in cash
-141.33%-2.27M
-235.69%-917.72K
2,371.33%6.59M
162.19%5.91M
-41.83%-511.75K
262.67%5.48M
181.36%676.33K
105.39%266.51K
-288.22%-9.51M
-111.92%-360.83K
End cash Position
41.46%9.86M
713.23%12.13M
1,500.49%13.05M
1,077.53%6.46M
1,077.53%6.46M
666.66%6.97M
-65.14%1.49M
-84.05%815.23K
-94.54%548.72K
-94.54%548.72K
Free cash flow
68.03%-2.17M
-223.76%-5.34M
-1.56%-3.24M
-21.02%-17.12M
-115.68%-5.48M
-101.30%-6.8M
51.50%-1.65M
33.84%-3.19M
-33.91%-14.14M
-10.12%-2.54M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 68.03%-2.17M-223.76%-5.34M-1.56%-3.24M-21.03%-17.11M-115.70%-5.47M-101.40%-6.8M51.50%-1.65M33.84%-3.19M-33.93%-14.14M-10.02%-2.54M
Net income from continuing operations 42.59%-3.22M6.16%-2.37M-21.34%-4.3M21.18%-14.86M40.91%-3.18M-23.95%-5.61M37.07%-2.53M28.13%-3.54M-23.42%-18.85M-4.64%-5.38M
Operating gains losses -------------138.15%-190--0--0--0---190-83.99%498-154.41%-259
Depreciation and amortization -7.19%69746.41%1.1K34.47%1.1K-20.03%3.31K3.36%985-16.46%751-25.02%752-36.04%818-64.83%4.13K-59.97%953
Other non cash items --------------596.3K--1--------------------
Change In working capital 149.70%1.03M-563.57%-2.99M567.84%995.95K-199.86%-3.69M-193.09%-2.43M-317.13%-2.06M96.85%645.26K180.94%149.13K16.90%3.7M18.17%2.61M
-Change in prepaid assets -27.10%401.66K-1,350.83%-1.68M505.05%623.16K-102.52%-59.97K-174.71%-597.9K-26.92%550.99K-188.70%-116.06K-85.12%102.99K176.28%2.38M391.67%800.26K
-Change in payables and accrued expense 125.53%667.2K-271.73%-1.31M708.01%372.78K-374.91%-3.63M-201.23%-1.83M-1,432.80%-2.61M286.57%761.32K105.26%46.14K-42.62%1.32M-27.18%1.81M
Cash from discontinued investing activities
Operating cash flow 68.03%-2.17M-223.76%-5.34M-1.56%-3.24M-21.03%-17.11M-115.70%-5.47M-101.40%-6.8M51.50%-1.65M33.84%-3.19M-33.93%-14.14M-10.02%-2.54M
Investing cash flow
Cash flow from continuing investing activities -7.36%-4.19K-94.16%-4.19K11.78%-3.9K-215,800.00%-2.16K
Net PPE purchase and sale -------------7.36%-4.19K-94.16%-4.19K------------11.78%-3.9K-215,800.00%-2.16K
Cash from discontinued investing activities
Investing cash flow -------------7.36%-4.19K-94.16%-4.19K------------11.78%-3.9K-215,800.00%-2.16K
Financing cash flow
Cash flow from continuing financing activities -100.75%-91.62K90.20%4.43M184.17%9.83M396.63%23.03M127.92%4.96M146,826.13%12.28M-9.52%2.33M2,975.33%3.46M-70.30%4.64M-59.17%2.18M
Net issuance payments of debt 1.18%-90.97K1.06%-88.91K0.93%-86.88K31.44%-300.81K55.87%-31.19K26.05%-92.06K26.76%-89.86K27.45%-87.7K-2.58%-438.73K10.73%-70.67K
Net common stock issuance -100.01%-1.49K86.09%4.51M155.60%9.03M908.65%23.38M2,220.75%5M9,244.01%12.41M23.12%2.42M--3.53M-85.55%2.32M-96.02%215.64K
Proceeds from stock option exercised by employees --844-68.80%2.78K--0-99.28%21.33K-100.00%-1--0-98.77%8.92K1,936.95%12.41K108,211.59%2.96M1,894,451.69%2.24M
Net other financing activities --0--0--882.54K67.10%-66.75K---10K---40K-----------202.86K----
Cash from discontinued financing activities
Financing cash flow -100.75%-91.62K90.20%4.43M184.17%9.83M396.63%23.03M127.92%4.96M146,826.13%12.28M-9.52%2.33M2,975.33%3.46M-70.30%4.64M-59.17%2.18M
Net cash flow
Beginning cash position 713.23%12.13M1,500.49%13.05M1,077.53%6.46M-94.54%548.72K666.66%6.97M-65.14%1.49M-84.05%815.23K-94.54%548.72K100.93%10.06M-87.06%909.55K
Current changes in cash -141.33%-2.27M-235.69%-917.72K2,371.33%6.59M162.19%5.91M-41.83%-511.75K262.67%5.48M181.36%676.33K105.39%266.51K-288.22%-9.51M-111.92%-360.83K
End cash Position 41.46%9.86M713.23%12.13M1,500.49%13.05M1,077.53%6.46M1,077.53%6.46M666.66%6.97M-65.14%1.49M-84.05%815.23K-94.54%548.72K-94.54%548.72K
Free cash flow 68.03%-2.17M-223.76%-5.34M-1.56%-3.24M-21.02%-17.12M-115.68%-5.48M-101.30%-6.8M51.50%-1.65M33.84%-3.19M-33.91%-14.14M-10.12%-2.54M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--
Market Insights
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +15.64%
Sample Name
Sample Code
 +12.57%
Sample Name
Sample Code
 +10.73%
4
Alibaba
BABA
+10.66%
5
Taiwan Semiconductor
TSM
+7.43%
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More
December FOMC Interest Rate Meeting
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?

- No more -